<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20190514043585N3</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-12-29</date_registration>
      <primary_sponsor>Tabriz University of Medical Sciences</primary_sponsor>
      <public_title>Evaluation of the effect of ozone gel on the clinical and radiographic success of ferric sulfate primary molar pulpotomy</public_title>
      <acronym></acronym>
      <scientific_title>Evaluation of the effect of ozone gel on the clinical and radiographic success of ferric sulfate primary molar pulpotomy</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-12-28</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>25</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/60664</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: The sampling method is randomly Available among Individuals referring to the pediatric department of Tabriz Dental faculty. The randomization method is simple. Our Tool for randomization is the randomized Number Chart. Furthermore, the Allocation of treatment to Patients is done Randomly. To do this, the types of treatment are identified with code A (control) and B (case) and then the sealed envelopes that will be placed in a box and stirred. Then they are randomly chosen from the Box and after observing the code, the treatment is given to the Patient. One person's tooth was considered as a control and another tooth for treatment, Blinding description: The pediatrician is unaware of the outcome of the treatment and the type of disinfectant used for each patient.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Primary tooth caries.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: In the experimental group, the procedure will be as follows: The desired tooth will be anesthetized and isolated with a Rubber Dam. After removing all caries and debris, an access cavity will be created. The contents of the coronary pulp tissue will be removed and then ozone gel (Vitomex) will be placed for disinfection After a few minutes of melting the gel, 15.5% ferric sulfate (UltraDent Astingedent) is placed in place and finally, zonalin (Zoliran) will be applied. and the final restoration will be done in the same meeting. This gel can stay at room temperature for months, but to maintain the highest performance, it must be stored in the refrigerator at 15 degrees Celsius or less. All steps will be performed by the student participating in the study under the supervision of the supervisor. Clinical success will be assessed by a pediatrician during a 6-month clinical follow-up. The pediatrician is unaware of the type of treatment given to each patient. Intervention 2: Control group: Normal pulpotomy using ferric sulfate. In the control group, the procedure will be as follows: The desired tooth will be anesthetized and isolated with a Rubber Dam. After removing all caries and debris, an access cavity will be created. The contents of the coronal pulp tissue will be extracted. 15.5% ferric sulfate (UltraDent Astingedent) will be placed in place and finally, zonalin (Zoliran) will be placed and the final repair will be done in the same session. In the control group, all the steps performed for the experimental group will be repeated, except Ozone gel will not be used for disinfection and eventually the crown of the teeth will be regenerated. All steps will be performed by the student participating in the study under the supervision of the supervisor. Clinical success will be assessed by a pediatrician during a 6-month clinical follow-up. The pediatrician is unaware of the type of treatment given to each patient.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is not more data</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Seyedeh Arezou Ghoreyshizadeh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Tabriz University of Medical Sciences, Golgasht St.</address>
        <city>Tabriz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5166614711</zip>
        <telephone>+98 41 3335 5965</telephone>
        <email>ghoreyshizadeha@tbzmed.ac.ir</email>
        <affiliation>Tabriz University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Seyedeh Arezou Ghoreyshizadeh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Tabriz University of Medical Sciences, Golgasht St.</address>
        <city>Tabriz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5166614711</zip>
        <telephone>+98 41 3335 5965</telephone>
        <email>ghoreyshizadeha@tbzmed.ac.ir</email>
        <affiliation>Tabriz University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Ages 4 to 8 years
The ability to cooperation for treatment
Double sided molar with irreversible pulpitis requires pulpectomy
Lack of symptoms of necrosis or inflammation of the root pulp in radiography
Lack of symptoms of external root resorption in radiography
Having primary radiography
Possibility of crown restoration
Parental satisfaction for participation in the study</inclusion_criteria>
      <agemin>4 years</agemin>
      <agemax>8 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Deficiency of glucose 6 phosphate dehydrogenase or favism
Hyperthyroidism
Anemia
Ozone sensitivity
Hemorrhagic disease</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>K02</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Dental caries</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: In the experimental group, the procedure will be as follows: The desired tooth will be anesthetized and isolated with a Rubber Dam. After removing all caries and debris, an access cavity will be created. The contents of the coronary pulp tissue will be removed and then ozone gel (Vitomex) will be placed for disinfection After a few minutes of melting the gel, 15.5% ferric sulfate (UltraDent Astingedent) is placed in place and finally, zonalin (Zoliran) will be applied. and the final restoration will be done in the same meeting. This gel can stay at room temperature for months, but to maintain the highest performance, it must be stored in the refrigerator at 15 degrees Celsius or less. All steps will be performed by the student participating in the study under the supervision of the supervisor. Clinical success will be assessed by a pediatrician during a 6-month clinical follow-up. The pediatrician is unaware of the type of treatment given to each patient.</i_keyword>
      <i_keyword>Control group: Normal pulpotomy using ferric sulfate. In the control group, the procedure will be as follows: The desired tooth will be anesthetized and isolated with a Rubber Dam. After removing all caries and debris, an access cavity will be created. The contents of the coronal pulp tissue will be extracted. 15.5% ferric sulfate (UltraDent Astingedent) will be placed in place and finally, zonalin (Zoliran) will be placed and the final repair will be done in the same session. In the control group, all the steps performed for the experimental group will be repeated, except Ozone gel will not be used for disinfection and eventually the crown of the teeth will be regenerated. All steps will be performed by the student participating in the study under the supervision of the supervisor. Clinical success will be assessed by a pediatrician during a 6-month clinical follow-up. The pediatrician is unaware of the type of treatment given to each patient.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Clinical success. Timepoint: 6 months. Method of measurement: A checklist containing information -1 No pain, 2-No sensitivity to Percussion 3-Missing or increased mobility 4- No opening of the sinus 5. No withdrawal of pushy exudates from the gingival margin.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tabriz University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-08-30</approval_date>
        <contact_name>Ethics committee of Tabriz University of Medical Sciences</contact_name>
        <contact_address>Floor2, Central Building No.2, Tabriz University of Medical Sciences, Golgasht St Tabriz East Azarbaijan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
